Tolerability of accelerated chest irradiation and impact on survival of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer: Review of a single institution's experience

Journal of Thoracic Oncology

Volumn 2, Issue 6, 2007, Pages 506-513

  Ng, Michael ^a   Chong, Jennifer ^a   Milner, Alvin ^a   MacManus, Michael ^a   Wheeler, Greg ^a   Wirth, Andrew ^a   Michael, Michael ^a   Ganju, Vinod ^b   McKendrick, Joe ^c   Ball, David ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b FRANKSTON HOSPITAL   (Australia)

^c BOX HILL HOSPITAL   (Australia)

Author keywords

Esophagitis; Lung cancer; Prophylactic cranial irradiation; Radiotherapy; Small cell

Indexed keywords

ADULT; AGED; BRAIN METASTASIS; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; ESOPHAGITIS; FEMALE; FOLLOW UP; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ADOLESCENT; ARTICLE; CANCER STAGING; LUNG TUMOR; MEGAVOLTAGE RADIOTHERAPY; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; SKULL IRRADIATION; SMALL CELL CARCINOMA; SURVIVAL RATE; THORAX WALL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; CRANIAL IRRADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SURVIVAL RATE; THORACIC WALL; TREATMENT OUTCOME;

EID: 34447120688     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318060095b     Document Type: Article

References (22)

1. Murray N, Turrisi A. A review of first-line treatment for small cell lung cancer. J Thorac Oncol 2006;270-278.
2. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618-1624.
3. Turrisi 3rd,AT Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-271.
4. Ball DL, Matthews JP. Prophylactic cranial irradiation: more questions than answers. Semin Radiat Oncol 1995;5:61-68.
5. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-484.
6. Ngan S, Ball D, Bull C, et al. Limited small cell lung cancer: the effect of radiotherapy on local control following response to chemotherapy. Int J Radiat Oncol Biol Phys 1991;21:459-462.
7. Stahel RA, Ginsberg R. Staging and prognostic factors in small cell lung cancer. Lung Cancer 1989;5:119-126.
8. Suwinski R, Lee SP, Withers HR. Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys 1998;40:797-806.
9. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-181.
10. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
11. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
12. Altman DG, De Stavola BL, Love SB, et al. Review of survival analyses published in cancer journals. Br J Cancer 1995;72:511-518.
13. S-Plus 2000. Seattle, WA: Insightful, 1999.
14. SPSS Advanced Statistics. Chicago: SPSS, Inc., 2001.
15. Schild SE, Bonner JA, Shanahan TG, et al. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;59:943-951.
16. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group study 9104. J Clin Oncol 2002;20:3054-3060.
17. Machtay M. The early rad catches the tumor? J Clin Oncol 2002;20:3045-3047.
18. Blum R, MacManus MP, Rischin D, et al. Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience. Am J Clin Oncol 2004;27:164-171.
19. Ellis PM, Delaney G, Della-Fiorentina S, et al. Assessing outcomes of cancer care: lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996-July 2000. Australas Radiol 2004;48:364-370.
20. Quoix E, Finkelstein H, Wolkove N, et al. Treatment of small-cell lung cancer on protocol: potential bias of results. J Clin Oncol 1986;4:1314-1320.
21. Tai TH, Yu E, Dickof P, et al. Prophylactic cranial irradiation revisited: cost-effectiveness and quality of life in small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52:68-74.
22. van Oosterhout AG, van de Pol M, ten Velde GP, et al. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 1996;77:1434-1441.